Genmab obtains both nobilities and turning point settlements from Novo Nordisk for possible sales of hit prospect mim8 for clients with hemophilia A.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/genmab-ceo-expects-limited-impact-from-potential-blockbuster-collaboration-with-novo-nordisk/